183
Views
5
CrossRef citations to date
0
Altmetric
Original Article

The activity of nintedanib in an animal model of allogenic left lung transplantation resembling aspects of allograft rejection

, , , , , & show all
Pages 259-270 | Received 19 Jan 2017, Accepted 09 Jul 2017, Published online: 16 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Elke Boxhammer, Karla Lehle, Christof Schmid & Marietta von Suesskind-Schwendi. (2020) Anti-oxidative effect of the tyrosine kinase inhibitor nintedanib: a potential therapy for chronic lung allograft dysfunction?. Experimental Lung Research 46:5, pages 128-145.
Read now

Articles from other publishers (4)

Julia Mauer, Annika Kuckhahn, Martina Ramsperger-Gleixner, Stephan M. Ensminger, Jörg H.W. Distler, Michael Weyand & Christian Heim. (2022) Nintedanib reduces alloimmune-induced chronic airway changes in murine tracheal allografts. Transplant Immunology 73, pages 101608.
Crossref
Saskia Bos, Laurens J. De Sadeleer, Arno Vanstapel, Hanne Beeckmans, Annelore Sacreas, Jonas Yserbyt, Wim A. Wuyts & Robin Vos. (2021) Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review. European Respiratory Review 30:160, pages 210050.
Crossref
Elisabeth Bendstrup, Wim Wuyts, Tiago Alfaro, Nazia Chaudhuri, Robin Cornelissen, Michael Kreuter, Kirsten Melgaard Nielsen, Anna-Marie B. Münster, Marjukka Myllärniemi, Claudia Ravaglia, Tim Vanuytsel & Marlies Wijsenbeek. (2019) Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events. Respiration 97:2, pages 173-184.
Crossref
Annika Gocht, Bernd Spriewald, Jörg H.W. Distler, Martina Ramsperger-Gleixner, Stephan M. Ensminger, Michael Weyand & Christian Heim. (2018) Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts. Transplantation Direct 4:7, pages e367.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.